S

Salubris Biotherapeutics

26 employees

SalubrisBio is a clinical-stage biotechnology company dedicated to discovering and developing novel antibody and protein-based therapeutics.

Basic info

Industry

biotechnology research

Sectors

Biotechnology
Antibody Engineering
Health Care
Antibody-Drug Conjugates
Cardiovascular
Oncology
Pharmaceutical
Bi-Specific Antibodies

Date founded

2016

Funding rounds raised

Total raised

$35M

from 2 investors over 2 rounds

S

Salubris Biotherapeutics raised $35M on March 28, 2023

Investors: Shenzhen Salubris Pharmaceuticals Co.,LTD

S

Salubris Biotherapeutics raised $32M on March 7, 2022

Investors: Shenzhen Salubris Pharmaceuticals Co.,LTD

FAQ